Affiliation:
1. Sharda University, India
2. Dublin City University, Ireland
3. Shinawatra University, Thailand
Abstract
The rapid progress in genetic research and technological advancements in recent years have revolutionized the field of reproductive medicine. Human genome and embryo editing, which involve the deliberate alteration of genetic material, hold immense potential for preventing genetic diseases, enhancing human traits, and even addressing infertility. However, these groundbreaking developments come with significant ethical, legal, and social implications that need to be carefully examined and addressed. The absence of a unified global regulatory framework for human genome and embryo editing has created a fragmented landscape. Various countries have adopted different approaches, ranging from strict regulations to more permissive policies. This chapter aims to provide a comprehensive analysis of the current state of affairs, highlighting the importance of establishing global standards to ensure responsible and equitable use of these technologies, while also prioritizing the protection of women's rights and ensuring reproductive justice.